Negative and paranoid symptoms are associated with negative performance beliefs and social cognition in 22q11.2 deletion syndrome

Schneider, Maude; Van der Linden, Martial; Menghetti, Sarah; Debbané, Martin; Eliez, S.

doi:10.1111/eip.12224

Article (Scientific journals)

Negative and paranoid symptoms are associated with negative performance beliefs and social cognition in 22q11.2 deletion syndrome

Schneider, Maude; Van der Linden, Martial; Menghetti, Sarah et al.

2017 • In Early Intervention in Psychiatry, 11 (2), p. 156-164

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/242574

DOI
10.1111/eip.12224

PubMed
25726949

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Schneider_Negative_217_PPA.pdf

Author postprint (221.54 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Article; Semantic Verbal Fluency Test; Schizophrenia, Paranoid; Adolescent; Child; Culture; Female; Genetic Predisposition to Disease; Humans; Male; Neuropsychological Tests; Pessimism; Psychometrics; Risk Factors; Schizotypal Personality Disorder; Young Adult

Abstract :

[en] Aims: 22q11.2 deletion syndrome (22q11.2DS) is a neurogenetic condition associated with an increased risk of developing schizophrenia. Previous studies have shown that negative symptoms represent the most specific clinical characteristic of psychosis in 22q11.2DS and are strongly associated with outcome. However, the psychological mechanisms associated with these symptoms in this population are poorly understood. In accordance with recent conceptualizations in the field of schizophrenia, the present study aims at investigating whether negative symptoms are associated with the presence of negative performance beliefs and cognitive deficits. Methods: Thirty-five participants with 22q11.2DS and 24 typically developing individuals aged between 11 and 24 years were included in the study. Self-reported schizotypal symptoms (cognitive-perceptual, paranoid, negative and disorganization symptoms) and dysfunctional beliefs (negative performance beliefs and need for approval) were assessed. Measures of processing speed, verbal memory, working memory, executive functioning and face recognition were also extracted from a broad cognitive evaluation protocol. Results: Adolescents with 22q11.2DS reported significantly higher score on the negative dimension of the Schizotypal Personality Questionnaire than controls, even when controlling for the influence of anxiety/depression and intellectual functioning. Negative and paranoid symptoms were associated with the severity of negative performance beliefs and lower face recognition abilities. Mediation analyses revealed that negative performance beliefs significantly mediated the association between face recognition and negative/paranoid symptoms. Conclusions: These findings suggest that negative performance beliefs and basic social cognitive mechanisms are associated with negative and paranoid symptoms in individuals with 22q11.2DS. Implications for intervention are discussed in this article. © 2015 Wiley Publishing Asia Pty Ltd

Disciplines :

Neurosciences & behavior

Author, co-author :

Schneider, Maude

Van der Linden, Martial ; Université de Liège - ULiège > Département de Psychologie > Département de Psychologie

Menghetti, Sarah; Office Médico-Pédagogique Research Unit, Department of Psychiatry, University of Geneva School of Medicine, Geneva, Switzerland

Debbané, Martin; Office Médico-Pédagogique Research Unit, Department of Psychiatry, University of Geneva School of Medicine, Geneva, Switzerland, Adolescence Clinical Psychology Research Unit, Faculty of Psychology, University of Geneva, Geneva, Switzerland

Eliez, S.; Office Médico-Pédagogique Research Unit, Department of Psychiatry, University of Geneva School of Medicine, Geneva, Switzerland, Department of Genetic Medicine and Development, University of Geneva School of Medicine, Geneva, Switzerland

Language :

English

Title :

Negative and paranoid symptoms are associated with negative performance beliefs and social cognition in 22q11.2 deletion syndrome

Publication date :

2017

Journal title :

Early Intervention in Psychiatry

ISSN :

1751-7885

Publisher :

Wiley, Oxford, United Kingdom

Volume :

Issue :

Pages :

156-164

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 29 December 2019

Statistics

Number of views

92 (3 by ULiège)

Number of downloads

113 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Bassett AS, McDonald-McGinn DM, Devriendt K et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159: 332–339.
Green T, Gothelf D, Glaser B et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 2009; 48: 1060–1068.
Murphy KC. Schizophrenia and velo-cardio-facial syndrome. Lancet 2002; 359: 426–430.
Murphy K, Jones L, Owen M. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940–945.
Armando M, Girardi P, Vicari S et al. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning. Schizophr Res 2012; 139: 151–156.
Baker KD, Skuse DH. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry 2005; 186: 115–120.
Debbané M, Glaser B, David MK, Feinstein C, Eliez S. Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 2006; 84: 187–193.
Schneider M, Van der Linden M, Glaser B et al. Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome. Psychiatry Res 2012; 196: 277–284.
Schneider M, Van der Linden M, Menghetti S, Glaser B, Debbané M, Eliez S. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome. J Psychiatr Res 2014; 48: 86–93.
Stoddard J, Niendam T, Hendren R, Carter C, Simon TJ. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res 2010; 118: 118–121.
Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 1991; 17: 555–564.
Debbané M, Van der Linden M, Glaser B, Eliez S. Source monitoring for actions in adolescents with 22q11.2 deletion syndrome (22q11.2DS). Psychol Med 2008; 38: 811–820.
Fervaha G, Foussias G, Agid O, Remington G. Amotivation and functional outcomes in early schizophrenia. Psychiatry Res 2013; 210: 665–668.
Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull 2010; 36: 359–369.
Lin C-H, Huang C-L, Chang Y-C et al. Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia. Schizophr Res 2013; 146: 231–237.
Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res 2009; 113: 189–199.
Kirkpatrick B, Fenton WS, Carpenter WT, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006; 32: 214–219.
Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34: 523–537.
Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull 2006; 32: 250–258.
Lewandowski KE, Cohen BM, Keshavan MS. Ongür D. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophr Res 2011; 133: 212–217.
Lipkovich IA, Deberdt W, Csernansky JG, Sabbe B, Keefe RS, Kollack-Walker S. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. BMC Psychiatry 2009; 9: 44.
McDowd J, Tang T-C, Tsai P-C, Wang S-Y, Su C-Y. The association between verbal memory, processing speed, negative symptoms and functional capacity in schizophrenia. Psychiatry Res 2011; 187: 329–334.
O'Gráda C, Barry S, McGlade N et al. Does the ability to sustain attention underlie symptom severity in schizophrenia? Schizophr Res 2009; 107: 319–323.
Szendi I, Kiss M, Racsmány M et al. Correlations between clinical symptoms, working memory functions and structural brain abnormalities in men with schizophrenia. Psychiatry Res 2006; 147: 47–55.
Clark LK, Warman D, Lysaker PH. The relationships between schizophrenia symptom dimensions and executive functioning components. Schizophr Res 2010; 124: 169–175.
Ventura J, Wood RC, Hellemann GS. Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis. Schizophr Bull 2013; 39: 102–111.
Rector NA, Beck AT, Stolar N. The negative symptoms of schizophrenia: a cognitive perspective. Can J Psychiatry 2005; 50: 247–257.
Zammit S, Allebeck P, David AS et al. A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry 2004; 61: 354–360.
MacCabe JH, Lambe MP, Cnattingius S et al. Scholastic achievement at age 16 and risk of schizophrenia and other psychoses: a national cohort study. Psychol Med 2008; 38: 1133–1140.
Couture SM, Blanchard JJ, Bennett ME. Negative expectancy appraisals and defeatist performance beliefs and negative symptoms of schizophrenia. Psychiatry Res 2011; 189: 43–48.
Grant PM, Beck AT. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophr Bull 2009; 35: 798–806.
Horan WP, Rassovsky Y, Kern RS, Lee J, Wynn JK, Green MF. Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia. J Psychiatr Res 2010; 44: 499–505.
Perivoliotis D, Morrison AP, Grant PM, French P, Beck AT. Negative performance beliefs and negative symptoms in individuals at ultra-high risk of psychosis: a preliminary study. Psychopathology 2009; 42: 375–379.
Rector NA. Dysfunctional attitudes and symptom expression in schizophrenia: differential associations with paranoid delusions and negative symptoms. J Cogn Psychother 2004; 18: 163–173.
Dumas P, Bouafia S, Gutknecht C, Saoud M, Dalery J, d'Amato T. [Validation of the French version of the Raine Schizotypal Personality Disorder Questionnaire–categorial and dimensional approach to schizotypal personality traits in a normal student population]. L'encéphale 2000; 26: 23–29.
Badoud D, Chanal J, Van der Linden M, Eliez S, Debbané M. [Validation study of the French Schizotypal Personality Questionnaire in a sample of adolescents: a confirmatory factor analysis]. L'encéphale 2011; 37: 299–307.
Stefanis NC, Smyrnis N, Avramopoulos D, Evdokimidis I, Ntzoufras I, Stefanis CN. Factorial composition of self-rated schizotypal traits among young males undergoing military training. Schizophr Bull 2004; 30: 335–350.
Bouvard M, Cottraux J, Charles S, Ciadella P, Guerin J, Aimard G. [Validation of a French version of Weissman & Beck's Dysfunctional Attitude Scale (DAS form A)]. Thérapie Comportementale et Cognitive 1994; 4: 127–135.
Weissman A. (January 1, 1979). The dysfunctional attitude scale: a validation study. Dissertation available from ProQuest. Paper AAI7919533. URL: http://repository.upenn.edu/dissertations/AAI7919533.
Chioqueta AP, Stiles TC. Factor structure of the Dysfunctional Attitude Scale (Form A) and the Automatic Thoughts Questionnaire: an exploratory study. Psychol Rep 2006; 99: 239–247.
Prenoveau JM, Zinbarg RE, Craske MG, Mineka S, Griffith JW, Rose RD. Evaluating the invariance and validity of the structure of dysfunctional attitudes in an adolescent population. Assessment 2009; 16: 258–273.
Achenbach TM, Rescorla LA. Manual for the ASEBA Adult Forms & Profiles. Burlington: University of Vermont, Research Center for Children, Youth & Families, 2003.
Achenbach TM, Rescorla LA. Manual for the ASEBA School-Age Forms & Profiles. Burlington: University of Vermont; Research Center for Children, Youth, & Families, 2001.
Wechsler D. Wechsler Adult Intelligence Scale-Third Edition. Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation, 1997.
Wechsler D. Wechsler Intelligence Scale for Children-Third Edition. Manual. San Antonio, TX: The Psychological Corporation, 1991.
Wechsler D. Manual for the Wechsler Memory Scale-Revised. San Antonio, TX: The Psychological Corporation, 1987.
Cohen M. Children's Memory Scale. London: The Psychological Corporation, 1997.
Wechsler D. Wechsler Intelligence Scale for Children-Fourth Edition. Manual. San Antonio, TX: The Psychological Corporation, 2005.
Benton A, Sivan A, Hamsher K, Varney N, Spreen O. Contribution to Neuropsychological Assessment. New York: Oxford University Press, 1983.
Preacher K Quantpsy. 2010 [Cited 10 Aug 2013.] Available from URL: http://www.quantpsy.org/sobel/sobel.htm
Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med 2001; 31: 189–195.
Reynolds CA, Raine A, Mellingen K, Venables PH, Mednick SA. Three-factor model of schizotypal personality: invariance across culture, gender, religious affiliation, family adversity, and psychopathology. Schizophr Bull 2000; 26: 603–618.
Vollema MG, Hoijtink H. The multidimensionality of self-report schizotypy in a psychiatric population: an analysis using multidimensional Rasch models. Schizophr Bull 2000; 26: 565–575.
Perivoliotis D, Cather C. Cognitive behavioral therapy of negative symptoms. J Clin Psychol 2009; 65: 815–830.
Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch Gen Psychiatry 2012; 69: 121–127.
Campbell LE, Azuma R, Ambery F et al. Executive functions and memory abilities in children with 22q11.2 deletion syndrome. Aust N Z J Psychiatry 2010; 44: 364–371.
Debbané M, Eliez S, Glaser B. Encoding and retrieval processes in Velo-Cardio-Facial Syndrome (VCFS). Neuropsychology 2008; 22: 226–234.
Niklasson L, Gillberg C. The neuropsychology of 22q11 deletion syndrome. A neuropsychiatric study of 100 individuals. Res Dev Disabil 2010; 31: 185–194.
Shashi V, Veerapandiyan A, Schoch K et al. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions. J Intellect Disabil Res 2012; 56: 865–878.
Gur RE, Yi JJ, McDonald-McGinn DM et al. Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities. Mol Psychiatry 2014; 19: 1205–1211.